RTX said net sales increased $8.9 billion on an organic basis in 2025, with organic sales growth at Pratt & Whitney of $4.8 billion, Collins of $2.6 billion, and Raytheon of $1.7 billion as the primary drivers.

1. 01

   RTX said net sales increased $8.9 billion on an organic basis in 2025, with organic sales growth at Pratt & Whitney of $4.8 billion, Collins of $2.6 billion, and Raytheon of $1.7 billion as the primary drivers.

2. 02

   The company said operating profit increased $2.8 billion in 2025 compared to 2024. It cited an increase in organic operating performance of its segments of $1.5 billion, gains on business dispositions, and the absence of $0.9 billion in charges related to the Resolution of Certain Legal Matters in 2024 as factors.

3. 03

   RTX said it received $1.2 billion from the sale of the actuation and flight control business in 2025 and $0.7 billion from the sale of the Simmonds Precision Products business. In 2024, it received $1.3 billion from the sale of the CIS business and $0.5 billion from the sale of the Goodrich Hoist & Winch business.

4. 04

   The company said it used Powder Metal Matter reserves for cash payments of $1.0 billion and customer credits in 2025 and 2024, respectively. It estimated the annual cash impact at approximately $0.7 billion in 2026.

Key figures

Fiscal year ended December 31, 2025

Revenue

$88.6B

Operating income

$9.3B

Net income

$6.7B

EPS

$4.96

Operating cash flow

$10.6B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.